BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  NovaRx Corporation Release: Lucanix Phase II Clinical Data Demonstrates Significantly Increased Survival In Lung Cancer Patients

  June 5, 2006

   · 

  3 min read
• Drug Development

  Eli Lilly and Company And Alkermes Complete Patient Enrollment For Phase 3 Safety Study For Inhaled Insulin For The Treatment Of Diabetes

  June 5, 2006

   · 

  6 min read
• Drug Development

  AstraZeneca PLC Release: New Data Show That Five Years Of Treatment With Arimidex(R) (Anastrozole) Did Not Cause Osteoporosis In Early Breast Cancer Patients With Normal Bone Mineral Density At Outset

  June 5, 2006

   · 

  5 min read
• Drug Development

  Cell Genesys, Inc. Reports Long-Term Follow-Up Data From Phase 2 Trial Of GVAX(R) Immunotherapy For Leukemia In Chronic Myelogenous Leukemia

  June 5, 2006

   · 

  5 min read
• Drug Development

  Bristol-Myers Squibb Company Release: Data From A Randomized Phase II Study Of Dasatinib Or 800 Mg/Day Imatinib- Mesylate (Gleevec(R)) Presented At The 42nd Annual Meeting Of The American Society of Clinical Oncology

  June 5, 2006

   · 

  2 min read
• Drug Development

  ZymoGenetics, Inc. Reports Encouraging IL-21 Phase 1b Results In Metastatic Melanoma And Renal Cell Cancer Presented At American Society of Clinical Oncology Meeting

  June 5, 2006

   · 

  5 min read
• Drug Development

  Medarex, Inc. Release: Ipilimumab (MDX-010) Shows Encouraging Data In Phase I And Phase II Clinical Trials For Hormone Refractory Prostate Cancer Patients

  June 5, 2006

   · 

  6 min read
• Current Industry-Related News Solidifies MediSys Corporation’s Medical Model

  June 5, 2006

   · 

  3 min read
• Drug Development

  Therion Biologics Corporation Reports Results Of Phase 2 PROSTVAC(R)-VF Trial At American Society of Clinical Oncology Annual Meeting And Formalizes Plan For An National Cancer Institute-Sponsored Phase 3 Study

  June 5, 2006

   · 

  5 min read
• Deals

  American Medical Systems, Inc. And Laserscope Announce Definitive $715 Million Merger Agreement

  June 5, 2006

   · 

  8 min read